International Journal of Biomedicine.2019;9 Suppl_1:S14-S15.
Originally published June 29, 2019
Background: Human plasma butyrylcholinesterase (hBChE, EC 184.108.40.206) is an endogenous bioscavenger that hydrolyzes numerous medicamentous and poisonous esters and scavenges potent organophosphorus nerve agents. Thus, the hBChE can be used to protect acetylcholinesterase as well as a marker for diagnosis of OP poisoning. It is also considered as a therapeutic target against Alzheimer’s disease. Though the X-ray structure of a partially deglycosylated monomer of human hBChE was solved 15 years ago, all attempts to determine the 3D structure of the natural full-length glycosylated tetrameric human hBChE were unsuccessful so far.
Methods: A combination of three complementary structural methods – single particle cryo-electron microscopy, molecular dynamic simulations and small-angle X-ray scattering were implemented to elucidate the overall structural and spatial organization of the natural tetrameric human plasma hBChE.
Results: A 7.6 Å cryo-EM map clearly shows the structural organization of the enzyme: a dimer of dimers with a non-planar monomer arrangement in which the interconnecting super helix complex PRAD-(WAT)4-peptide C-terminal tail is located in the center of the tetramer, nearly perpendicular to its plane and deeply plunged between the four subunits. Time-averaged molecular dynamics trajectories allowed to optimize the geometry of the molecule and to reconstruct structural features obscured in the cryoEM density, e.g glycan chains and glycan inter-dimer contact areas as well as inter-monomer disulfide bridges at the C-terminal tail. Finally, SAXS data confirmed the consistency of the obtained model with the experimental data.
Conclusion: The 3D structure of human tetrameric butyrylcholinesterase, obtained for the first time using a combination of complementary structural methods, revealed unique quaternary organization distinct from the model proposed previously.